NAT10 and cancer: Using AlphaFold2 to predict the NAT10 protein structure with high confidence, followed by molecular docking simulations via the AutoDock algorithm, we screened a library of over 4300 anti‐cancer small molecules from MCE to calculate their binding affinities with NAT10 (Figure 7A,B).